CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Open-market sale Chief Development Officer sold 1,384 shares at $78.57 ($108,741)
- 4 Open-market sale Chief Human Resources Officer sold 718 shares at $79.04 ($56,749)
- 4 Open-market sale Chief Financial Officer sold 885 shares at $79.04 ($69,948)
- 4 Open-market sale Chief Operating Officer sold 296 shares at $79.04 ($23,395)
- 4 Open-market sale Chief Commercial Officer sold 269 shares at $79.04 ($21,261)
- 4 Open-market sale Chief Development Officer sold 14,796 shares at an average $77.50 ($1,146,634)
- 4 Open-market sale Chief Medical Officer sold 5,959 shares at an average $73.73 ($439,328)
- 4 Grant or award Chief Financial Officer acquired 7,122 shares (grant or award)
- 4 Open-market sale Executive Chairman sold 837 shares at $69.66 ($58,305)
- 4 Open-market sale Chief Medical Officer sold 437 shares at $69.66 ($30,441)
- 4 Open-market sale Chief Development Officer sold 414 shares at $69.66 ($28,839)
- 4 Grant or award Chief Science Officer acquired 281 shares (grant or award)
- 4 Grant or award General Counsel acquired 144 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 251 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 218 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 276 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 222 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 312 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 312 shares (grant or award)
- 4 Grant or award Chief Human Resources Officer acquired 213 shares (grant or award)
Page 11 of 39 · 780 filings